Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate

doi:10.5306/wjco.v7.i2.160

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9415)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

640

WORD

430

HTML

5215

Figures (1-7)

283

Tables (1-1)

247

Sum=6815

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1025

Download

1575

Sum=2600

Apr 10, 2016 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. Apr 10, 2016; 7(2): 160-173
Published online Apr 10, 2016. doi: 10.5306/wjco.v7.i2.160

Full Size Figure Download Figure

Figure 7 Kaplan-Meier plot for distant recurrence-free survival of 394 breast cancer patients treated with Tamoxifen. Patients with (blue) and without (red) estrogen receptor alpha gene amplification in primary tumor. From Singer et al[41].

Citation: Holst F. Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate. World J Clin Oncol 2016; 7(2): 160-173
URL: https://www.wjgnet.com/2218-4333/full/v7/i2/160.htm
DOI: https://dx.doi.org/10.5306/wjco.v7.i2.160